Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina

Autores
Burgos, Lucrecia María; Benzadón, Mariano; Candiello, Alfonsina; Cabral, Miguel Héctor; Conde, Diego; Alves de Lima, Alberto Enrique; Belardi, Jorge; Diez, Mirta
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, virtual visits (VVs) were recommended as an innovative and necessary alternative for patients with heart failure (HF). To assess the feasibility and acceptability of VVs in patients with HF, pulmonary hypertension (PH), and heart transplant (HT). Methods: We designed a single-centre cohort study. Consecutive VVs performed in our HF unit were analysed. The period comprehended between January 1st and March 19th (before COVID-19) and March 20th and June 30th (during COVID-19) was compared. We assessed acceptability, feasibility and the need for diagnostic studies, in-person medical evaluation, and hospitalization at 30 days. Results: HF unit medical doctors conducted 22 VVs in the pre-COVID period and 416 VVs during the COVID period. The VV was able to be performed in all patients scheduled for it and 44% answered the survey. Ninety percent of the patients who answered the survey strongly agreed that VVs were easy to be carried out. All the patients “strongly agreed” or “agreed” that their health problem could be resolved. Most patients (95%) rated the global experience as very good or excellent, with an overall average rate of 9.76±0.5 out of 10. We found no differences regarding the requirement of diagnostic studies, in-person medical evaluation and hospitalization during the first month after VVs between the 2 periods. Conclusions: VVs were feasible, presented high acceptability, and the overall experience was positive in patients with HF, PH, and HT, being this modality a valuable tool that complements in-person care.
Fil: Burgos, Lucrecia María. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Benzadón, Mariano. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Candiello, Alfonsina. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Cabral, Miguel Héctor. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Conde, Diego. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Alves de Lima, Alberto Enrique. Instituto Cardiovascular de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Belardi, Jorge. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Diez, Mirta. Instituto Cardiovascular de Buenos Aires; Argentina
Materia
HEART FAILURE
TELEHEALTH
SARS-COV-2
PANDEMIC
COVID-19
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/122668
Acceder
id CONICETDig_86610f419f949a779a9d7646e5b6ef7b
oai_identifier_str oai:ri.conicet.gov.ar:11336/122668
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in ArgentinaBurgos, Lucrecia MaríaBenzadón, MarianoCandiello, AlfonsinaCabral, Miguel HéctorConde, DiegoAlves de Lima, Alberto EnriqueBelardi, JorgeDiez, MirtaHEART FAILURETELEHEALTHSARS-COV-2PANDEMICCOVID-19https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, virtual visits (VVs) were recommended as an innovative and necessary alternative for patients with heart failure (HF). To assess the feasibility and acceptability of VVs in patients with HF, pulmonary hypertension (PH), and heart transplant (HT). Methods: We designed a single-centre cohort study. Consecutive VVs performed in our HF unit were analysed. The period comprehended between January 1st and March 19th (before COVID-19) and March 20th and June 30th (during COVID-19) was compared. We assessed acceptability, feasibility and the need for diagnostic studies, in-person medical evaluation, and hospitalization at 30 days. Results: HF unit medical doctors conducted 22 VVs in the pre-COVID period and 416 VVs during the COVID period. The VV was able to be performed in all patients scheduled for it and 44% answered the survey. Ninety percent of the patients who answered the survey strongly agreed that VVs were easy to be carried out. All the patients “strongly agreed” or “agreed” that their health problem could be resolved. Most patients (95%) rated the global experience as very good or excellent, with an overall average rate of 9.76±0.5 out of 10. We found no differences regarding the requirement of diagnostic studies, in-person medical evaluation and hospitalization during the first month after VVs between the 2 periods. Conclusions: VVs were feasible, presented high acceptability, and the overall experience was positive in patients with HF, PH, and HT, being this modality a valuable tool that complements in-person care.Fil: Burgos, Lucrecia María. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Benzadón, Mariano. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Candiello, Alfonsina. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Cabral, Miguel Héctor. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Conde, Diego. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Alves de Lima, Alberto Enrique. Instituto Cardiovascular de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Belardi, Jorge. Instituto Cardiovascular de Buenos Aires; ArgentinaFil: Diez, Mirta. Instituto Cardiovascular de Buenos Aires; ArgentinaKorean Society of Heart Failure2020-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/122668Burgos, Lucrecia María; Benzadón, Mariano; Candiello, Alfonsina; Cabral, Miguel Héctor; Conde, Diego; et al.; Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina; Korean Society of Heart Failure; International Journal of Heart Failure; 2; 2; 12-2020; 247-2532636-154X2636-1558CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.36628/ijhf.2020.0025info:eu-repo/semantics/altIdentifier/url/https://e-heartfailure.org/DOIx.php?id=10.36628/ijhf.2020.0025info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:49:40Zoai:ri.conicet.gov.ar:11336/122668instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:49:41.094CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
title Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
spellingShingle Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
Burgos, Lucrecia María
HEART FAILURE
TELEHEALTH
SARS-COV-2
PANDEMIC
COVID-19
title_short Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
title_full Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
title_fullStr Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
title_full_unstemmed Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
title_sort Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
dc.creator.none.fl_str_mv Burgos, Lucrecia María
Benzadón, Mariano
Candiello, Alfonsina
Cabral, Miguel Héctor
Conde, Diego
Alves de Lima, Alberto Enrique
Belardi, Jorge
Diez, Mirta
author Burgos, Lucrecia María
author_facet Burgos, Lucrecia María
Benzadón, Mariano
Candiello, Alfonsina
Cabral, Miguel Héctor
Conde, Diego
Alves de Lima, Alberto Enrique
Belardi, Jorge
Diez, Mirta
author_role author
author2 Benzadón, Mariano
Candiello, Alfonsina
Cabral, Miguel Héctor
Conde, Diego
Alves de Lima, Alberto Enrique
Belardi, Jorge
Diez, Mirta
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv HEART FAILURE
TELEHEALTH
SARS-COV-2
PANDEMIC
COVID-19
topic HEART FAILURE
TELEHEALTH
SARS-COV-2
PANDEMIC
COVID-19
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, virtual visits (VVs) were recommended as an innovative and necessary alternative for patients with heart failure (HF). To assess the feasibility and acceptability of VVs in patients with HF, pulmonary hypertension (PH), and heart transplant (HT). Methods: We designed a single-centre cohort study. Consecutive VVs performed in our HF unit were analysed. The period comprehended between January 1st and March 19th (before COVID-19) and March 20th and June 30th (during COVID-19) was compared. We assessed acceptability, feasibility and the need for diagnostic studies, in-person medical evaluation, and hospitalization at 30 days. Results: HF unit medical doctors conducted 22 VVs in the pre-COVID period and 416 VVs during the COVID period. The VV was able to be performed in all patients scheduled for it and 44% answered the survey. Ninety percent of the patients who answered the survey strongly agreed that VVs were easy to be carried out. All the patients “strongly agreed” or “agreed” that their health problem could be resolved. Most patients (95%) rated the global experience as very good or excellent, with an overall average rate of 9.76±0.5 out of 10. We found no differences regarding the requirement of diagnostic studies, in-person medical evaluation and hospitalization during the first month after VVs between the 2 periods. Conclusions: VVs were feasible, presented high acceptability, and the overall experience was positive in patients with HF, PH, and HT, being this modality a valuable tool that complements in-person care.
Fil: Burgos, Lucrecia María. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Benzadón, Mariano. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Candiello, Alfonsina. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Cabral, Miguel Héctor. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Conde, Diego. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Alves de Lima, Alberto Enrique. Instituto Cardiovascular de Buenos Aires; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Belardi, Jorge. Instituto Cardiovascular de Buenos Aires; Argentina
Fil: Diez, Mirta. Instituto Cardiovascular de Buenos Aires; Argentina
description Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, virtual visits (VVs) were recommended as an innovative and necessary alternative for patients with heart failure (HF). To assess the feasibility and acceptability of VVs in patients with HF, pulmonary hypertension (PH), and heart transplant (HT). Methods: We designed a single-centre cohort study. Consecutive VVs performed in our HF unit were analysed. The period comprehended between January 1st and March 19th (before COVID-19) and March 20th and June 30th (during COVID-19) was compared. We assessed acceptability, feasibility and the need for diagnostic studies, in-person medical evaluation, and hospitalization at 30 days. Results: HF unit medical doctors conducted 22 VVs in the pre-COVID period and 416 VVs during the COVID period. The VV was able to be performed in all patients scheduled for it and 44% answered the survey. Ninety percent of the patients who answered the survey strongly agreed that VVs were easy to be carried out. All the patients “strongly agreed” or “agreed” that their health problem could be resolved. Most patients (95%) rated the global experience as very good or excellent, with an overall average rate of 9.76±0.5 out of 10. We found no differences regarding the requirement of diagnostic studies, in-person medical evaluation and hospitalization during the first month after VVs between the 2 periods. Conclusions: VVs were feasible, presented high acceptability, and the overall experience was positive in patients with HF, PH, and HT, being this modality a valuable tool that complements in-person care.
publishDate 2020
dc.date.none.fl_str_mv 2020-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/122668
Burgos, Lucrecia María; Benzadón, Mariano; Candiello, Alfonsina; Cabral, Miguel Héctor; Conde, Diego; et al.; Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina; Korean Society of Heart Failure; International Journal of Heart Failure; 2; 2; 12-2020; 247-253
2636-154X
2636-1558
CONICET Digital
CONICET
url http://hdl.handle.net/11336/122668
identifier_str_mv Burgos, Lucrecia María; Benzadón, Mariano; Candiello, Alfonsina; Cabral, Miguel Héctor; Conde, Diego; et al.; Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina; Korean Society of Heart Failure; International Journal of Heart Failure; 2; 2; 12-2020; 247-253
2636-154X
2636-1558
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.36628/ijhf.2020.0025
info:eu-repo/semantics/altIdentifier/url/https://e-heartfailure.org/DOIx.php?id=10.36628/ijhf.2020.0025
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Korean Society of Heart Failure
publisher.none.fl_str_mv Korean Society of Heart Failure
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613535747801088
score 13.070432

Publicaciones similares